原文标题： 川普称药品关税最终可能达到250% ※请勿删减原文标题 原文连结： https://reurl.cc/XQE7g0 ※网址超过一行过长请用缩网址工具 发布时间： AUG 5 20258:30 AM EDT ※请以原文网页/报纸之发布时间为准 记者署名： Annika Kim Constantino ※原文无记载者得留空 原文内容： President Donald Trump told CNBC’s “Squawk Box” on Tuesday that planned tarif fs on pharmaceuticals imported into the U.S. could eventually reach up to 250%, the highest rate he has threatened so far. He said he will initially impose a ? small tariff” on pharmaceuticals, but then in a year to a year and a half “max imum,” he will raise that rate to 150% and then 250%. The president has repeat edly threatened and then changed course on tariff proposals, so there’s no guar antee he will eventually set pharmaceutical tariffs at the 250% rate. In early J uly, Trump had threatened 200% tariffs on pharmaceuticals. The Trump administra tion in April initiated a so-called Section 232 investigation on pharmaceutical products. That’s a legal authority that allows the secretary of Commerce to inv estigate the impact of imports on national security. The tariffs are the presid ent’s bid to incentivize drug companies to move manufacturing operations to the U.S. at a time when domestic drug manufacturing has shrunk dramatically over th e last few decades. Over the last six months, companies like Eli Lilly and John son & Johnson have announced fresh U.S. investments to build goodwill with the president. “We want pharmaceuticals made in our country,” Trump told CNBC. T he planned levies would deal a blow to the pharmaceutical industry, which has wa rned that the tariffs could drive up costs, deter investments in the U.S. and di srupt the drug supply chain, putting patients at risk. Drugmakers are already na vigating the fallout from Trump’s drug pricing policies, which they argue threa ten both their bottom lines and their capacity to invest in research and develop ment. That includes Trump’s executive order in May that revives a controversia l plan, the “most favored nation” policy, that aims to slash drug costs by tyi ng the prices of some medicines in the U.S. to the significantly lower ones abro ad. On Tuesday, Trump told CNBC that he “invoked” the “most favored nations? policy and that it will have a “tremendous impact on the price of medicine.” But Trump has not officially implemented any changes from the executive order. Trump last week sent letters to 17 drugmakers calling on them to commit to steps to lower U.S. drug prices by Sept. 29. That includes agreeing to provide their full portfolio of existing medicines at the lowest price offered in other develo ped nations to every single Medicaid patient, among other steps. Some pharmaceu tical companies have said they are reviewing the letters. 川普总统周二在 CNBC 节目《Squawk Box》中表示，拟针对进口到美国的药品徵收的关税， 最终可能高达 250%，这是他迄今为止威胁的最高税率。 他说，最初会对药品徵收「小额关税」，但在一年到一年半「最长」时间内，他将把税率先 提高到 150%，然後再调升至 250%。 总统多次威胁过药品关税，却又改变决策，因此并不保证他最终真的会将药品关税设定为 2 50%。在七月初，川普曾威胁要对药品徵收 200% 的关税。 川普政府在四月份启动了所谓的「232条款」调查，针对药品进口进行调查。该条款授权商? 部长评估进口品对国家安全的影响。 这些关税是总统为了鼓励药厂将制造业务移回美国所提出的策略，因为过去几十年来，美国 国内的药品制造业大幅萎缩。过去六个月内，诸如礼来（Eli Lilly）和强生（Johnson & J ohnson）等公司都已宣布新的美国投资，以示对总统的善意。 「我们要让药品在我们国内制造，」川普在 CNBC 上表示。 这些拟议徵税将对制药业造成打击，药厂警告说，此举可能推高成本、抑制美国投资，并扰 乱药品供应链，危及病患用药安全。药厂已在应对川普的药价政策冲击，他们认为这些政策 既威胁利润，也影响研发投资。 其中就包括川普在五月签署的行政命令，重新启动具争议的「最惠国」政策，旨在将部分美 国药品价格与其他国家显着较低的药价挂钩，以大幅削减药价。 周二，川普告诉 CNBC，他已「引用」最惠国政策，并认为此举将对药价产生「巨大影响」? 不过，川普尚未正式落实该行政命令中的任何变更。 上周，川普向 17 家药厂寄发信函，要求它们在 9 月 29 日前承诺采取措施降低美国药价? 包括同意将其现有全线药品的最低海外价格，提供给所有单一的联邦医疗补助 (Medicaid) 患者等多项做法。 一些制药公司表示正在审阅这些信函。 心得/评论： 主委越来越聪明了欸 说警告你说一年後没来就250% 药品是这样 看来半导体也一样 先警告你一年後你没到自己看着办 不过台积最近比较危险还是外流 有买的自己加油 ※必需填写满30正体中文字，无意义者板规处分 ---- Sent from BePTT on my iPhone 12 Pro --

※ 发信站: 批踢踢实业坊(ptt.cc), 来自: 223.137.110.201 (台湾) ※ 文章网址: https://webptt.com/cn.aspx?n=bbs/Stock/M.1754400554.A.432.html ※ 编辑: c259888 (223.137.110.201 台湾), 08/05/2025 21:31:29 重点是其他竞争者都跟你一样不去？ 还是他们去你没去 他没关税你250% 你竞争力直接归零 ※ 编辑: c259888 (223.137.110.201 台湾), 08/05/2025 21:34:26